Recital 5, Regulation (EU) 2026/2024

In forcesince 10 Sep 2026

On 6 November 2025, the Agency submitted, in accordance with Article 12(4) of Implementing Regulation (EU) No 354/2013, an opinion [Biocidal Products Committee (BPC) opinion on the minor change to the Union authorisation of the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ of 6 November 2025, ECHA/BPC/505/2025 https://echa.europa.eu/opinions-on-union-authorisation.] on the applied minor changes to the Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ together with a revised SPC and a revised assessment report. The opinion concludes that the proposed changes are minor changes as defined in Article 3(1), point (ab), of Regulation (EU) No 528/2012 and as specified in Title 2 of the Annex to Implementing Regulation (EU) No 354/2013, and that after the implementation of the changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.